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AbstrACt
Objectives Sex differences in prevalence of neural tube 
defects (NTDs) have previously been recognised; however, 
the different susceptibility of men and women have not 
been examined in relation to the effects of folic acid (FA) 
supplementation. We hypothesised that FA may have a 
disproportionate effect that alters the sex-specific prevalence 
of NTDs.
setting Data from two time points, before (2003–2004) 
and after (2011–2016) the start of the supplementation 
programme, were obtained from a population-based birth 
defect surveillance programme among five counties in 
northern China. All live births (28 or more complete gestational 
weeks), all stillbirths of at least 20 weeks’ gestational age and 
pregnancy terminations at any gestational age following the 
prenatal diagnosis of NTDs were included.
Participants A total of 25 249 and 83 996 births before and 
after the programme were included respectively.
Primary and secondary outcome measures The 
prevalence of NTDs by sex and subtype, Male:female rate 
ratios and their 95% CI were calculated.
results Overall, NTDs were less prevalent among men than 
among women (rate ratio (RR) 0.92; 95% CI 0.90 to 0.94), 
so was anencephaly (RR 0.77; 95% CI 0.73 to 0.81) and 
encephalocele (RR 0.75; 95% CI 0.61 to 0.92), while spina 
bifida showed a male predominance (RR 1.10; 95% CI 1.05 
to 1.15). The overall prevalence of NTDs decreased by 78/10 
000 in men and 108.7/10 000 in women from 2003 to 2004 
to 2011 to 2016. There was a significant sex difference in the 
magnitude of reduction, being greater in women than men, 
particularly for anencephaly.
Conclusions The prevalence of NTDs decreased in 
both sexes after the implementation of a massive FA 
supplementation programme. While female predominance 
was observed in open NTDs and total NTDs, they also had a 
greater rate of decrease in NTDs after the supplementation 
programme.
IntrOduCtIOn  
The prevalence of many types of birth defects 
appears to differ by sex, with the majority 
of them being more prevalent among 
men,1 2 including orofacial cleft (cleft lip 
with or without cleft palate), urinary system 
(hypospadias, hydronephrosis) and gastro-
intestinal tract (diaphragmatic hernia). 
However, some types of neural tube defects 
(NTDs) occur more frequently in women 
(eg, isolated cases of cranial defects, such 
as anencephaly).3 4 Women tend to have 
anencephaly more often than men, while 
craniorachischisis and spina bifida involving 
the higher spine may also show a prepon-
derance among women.4 By contrast, there 
tends to be a higher proportion of men than 
women with spina bifida affecting the lower 
spine.4 There are thought to be multiple initi-
ation sites in human neural tube closure,5 
as described in other mammalian embryos. 
Neural tube closure occurs during weeks 3–4 
of human gestation and the sex of the embryo 
strengths and limitations of this study
 ► Our data are from a population-based surveillance 
system, which covered all live births (28 or more 
complete gestational weeks), and neural tube de-
fect (NTD) cases from pregnancies of any gestation-
al age.
 ► NTDs decreased among both men and women after 
the implementation of a massive folic acid (FA) sup-
plementation programme in China, while these de-
creases were significantly greater in women than in 
men.
 ► The reduction in NTD cases during the post-FA pe-
riod inversely mirrors the increase in plasma folate 
concentrations among pregnant women.
 ► Limitations of our study include that covering small 
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is differentially associated with a lack of closure of specific 
areas of the neural tube.5 
Female predisposition to anencephaly is also observed 
among a number of mouse models,3 6 but the mechanism 
underlying this has not been established. In mice, female 
embryos tend to be developmentally delayed compared 
with their male littermates at neurulation stages, leading 
to the hypothesis that the longer duration of cranial 
neural tube closure would lead to greater susceptibility to 
NTD-causing insult. However, going against this hypoth-
esis, the delay in development may occur prior to neural 
tube closure, with female and male embryos taking the 
same time to complete cranial neurulation.7 Other 
suggested mechanisms include sex differences in genetic 
risk, epigenetic factors, a differential rate of fetal loss and 
susceptibility to environmental influences.8
Among environmental factors, periconceptional 
supplementation with folic acid (FA) has been shown to 
dramatically reduce the risk for NTDs in offspring9 and, 
conversely, suboptimal maternal folate status is a risk 
factor for NTDs.10 Although a large number of studies 
have investigated the preventive effects of FA on NTDs, 
the influence of maternal FA supplementation on sex-as-
sociated risk for NTDs and their subtypes is unclear. 
Some studies have lacked data on the type of NTDs or 
sex,11 while others have not found significant differences 
among subtypes of NTD.12 In these studies, the apparent 
protective effects of FA do not seem to act preferentially 
in one region of the neural tube and there appears to be a 
general reduction in the occurrence of human NTDs.13 In 
a study in Mexico in which weekly administration of 5 mg 
FA was associated with a 50% reduction in the incidence 
of NTDs, the main effect was on spina bifida, with a higher 
reduction in female cases.8 In several countries, FA fortifi-
cation (FAF) of food has been associated with a decreased 
frequency of spina bifida and anencephaly on a popula-
tion level.14 15 A recent study from South America showed 
that prevalence of NTDs, particularly anencephaly and 
cervicothoracic spina bifida, showed a greater reduc-
tion rate in women than in men after FAF resulting in a 
change of the sex ratio of infants with NTDs.16
In 2009, the Ministry of Health of China initiated a 
nationwide FA supplementation programme for the 
purpose of further decreasing the occurrence of NTDs in 
the country.17 Women with a rural household registration 
and planning to become pregnant are eligible to obtain 
FA supplements free of charge through the maternal 
healthcare system. In a recent study, we showed that 
birth prevalence of NTDs in the five counties of Shanxi 
Province in northern China dropped dramatically, from 
118.9/10 000 in 2000 to 31.5/10 000 in 2014.18 In the 
present study, we examined the trends in NTD preva-
lence by sex in five counties of Shanxi Province, China, 
from 2003 to 2016, encompassing the introduction of a 
massive FA supplementation campaign. Characterisation 
of the sex distribution of NTDs may be helpful to better 




Five counties in Shanxi Province (Pingding, Xiyang, 
Taigu, Zezhou and Shouyang) were included in a popula-
tion-based birth defects surveillance system in the current 
study. The surveillance system was similar to a previously 
reported system, created to meet the primary objective 
of monitoring the prevalence of major structural birth 
defects including NTDs.19 A national FA supplementation 
programme was initiated in China in 2009; therefore, in 
the current study, we collected data at two time points: 
before (2003–2004) and after (2011–2016) the start of 
the supplementation programme. All pregnant women 
who resided in the study area for more than 1 year during 
the period were monitored. All live births (28 or more 
complete gestational weeks), all stillbirths of at least 20 
weeks’ gestational age and pregnancy terminations at any 
gestational age following the prenatal diagnosis of NTDs 
were included. Photographs of every suspected case were 
obtained. NTD diagnosis was conducted by local special-
ists in maternal-fetal medicine, and photographs were 
sent to a paediatrician at Peking University for confirma-
tion. The study protocol was reviewed and approved.
statistical analysis
The prevalence of NTDs by infant sex was analysed sepa-
rately for open NTDs (anencephaly, spina bifida)20 and 
encephalocele. The denominator was the total number 
of all births and pregnancy that reached 28 or more 
complete gestational weeks by sex; the numerator was 
the number of NTD cases regardless of gestational age 
by sex. The prevalence of NTDs by sex and subtype were 
compared using χ2 tests. A difference in differences (DID) 
model was applied to compare sex differences between 
the time periods.21 A two-tailed p≤0.05 was considered to 
indicate statistically significant differences. All statistical 
analyses were performed using the SPSS package V.20.0 
(SPSS, Chicago, USA).
Patient and public involvement
Our main analysis was based on the birth defects surveil-
lance system; the information was anonymised. Patients 
and or public were not involved.
results
Prevalence before FA supplementation programme
The prevalence of NTDs by subtype and sex is shown in 
table 1. Before the programme, a total of 25 249 births and 
341 cases of NTDs (156 men, 185 women) were recorded 
in the system. The overall prevalence of NTDs for both 
sexes was 135.1/10 000, comprising 118.6/10 000 among 
men and 152.9/10 000 among women. All subtypes 
except spina bifida were more prevalent among women 
with a male-to-female rate ratio (RR) of 0.60 (95% CI 0.45 
to 0.80) and 0.79 (95% CI 0.77 to 0.81) for encephalo-
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Prevalence during FA supplementation programme
After the initiation of the programme, a total of 83 996 
births and 356 cases of NTDs (177 men, 179 women) 
were recorded in the system. The overall prevalence for 
both sexes was 43.3/10 000, being 40.7/10 000 among 
men and 44.2/10 000 among women. Hence, in sum, 
NTDs were less prevalent among men than women (RR 
0.92; 95% CI 0.90 to 0.94), as was anencephaly (RR 0.77; 
95% CI 0.73 to 0.81) and encephalocele (RR 0.75; 95% CI 
0.61 to 0.92), while spina bifida showed male predomi-
nance (RR 1.10; 95% CI 1.05 to 1.15) (table 1).
differences in changes in prevalence rates of ntds
After the supplementation period, the prevalence of all 
types of NTDs was lower in both male and female fetuses. 
However, there was a significant sex difference in the 
magnitude of reduction, being more pronounced among 
women, especially for open NTDs including anencephaly 
(p<0.01). The overall prevalence of NTDs decreased by 
78/10 000 in men and 108.7/10 000 in women in abso-
lute terms; anencephaly decreased by 70.3% in men and 
75.5% in women in relative term (table 2).
dIsCussIOn
This quasi-experimental population-based study exam-
ined whether introduction of population-wide FA supple-
mentation was associated with changes in the sex ratio 
for NTDs prevalence in northern China, as a means to 
understand whether the preventive effects of FA supple-
mentation differ by sex. We found that, after the intro-
duction of the national FA supplementation campaign, 
the prevalence of total NTDs and open NTDs (including 
anencephaly and spina bifida) decreased among both 
sexes. However, the magnitude of decline was signifi-
cantly greater among women than men.
Table 1 Prevalence rates of NTDs (per 10 000 births) by type and sex in Shanxi Province, China, in 2003–2004 and 2011–
2016
NTDs type
Male Female M:F rate ratio
Births Cases Rate Births Cases Rate RR 95% CI
2003–2004 (Pre-FA supplementation)
13 150 12 099
Open NTDs 145 110.3 168 138.9 0.79 0.77 0.81
  Anencephaly 65 49.4 94 77.7 0.64 0.61 0.67
  Spina bifida 80 60.8 74 61.2 0.99 0.94 1.04
Encephalocele 11 8.4 17 14.1 0.60 0.45 0.80
Total NTDs 156 118.6 185 152.9 0.78 0.76 0.80
2011–2016 (Post-FA supplementation)
43 538 40 458
Open NTDs 160 36.7 158 39.1 0.94 0.92 0.96
  Anencephaly 64 14.7 77 19.0 0.77 0.73 0.81
  Spina bifida 96 22.0 81 20.0 1.10 1.05 1.15
Encephalocele 17 3.9 21 5.2 0.75 0.61 0.92
Total NTDs 177 40.7 179 44.2 0.92 0.90 0.94
NTDs, neural tube defects; RR, relative risk.
Table 2 Differences in changes in prevalence rates of NTDs (per 10 000 births) by type and sex in Shanxi Province, China, in 
2003–2004 and 2011–2016
Types
Male rate Female rate Female–Male 
DID value P valuesAbsolute Relative Absolute Relative
Open NTDs 73.5 66.7 99.8 71.9 26.3 0.001
  Anencephaly 34.7 70.3 58.7 75.5 23.9 0.001
  Spina bifida 38.8 63.8 41.1 67.3 2.4 0.765
Encephalocele 4.5 53.3 8.9 63.1 4.4 0.213
Total NTDs 78.0 65.7 108.7 71.1 30.7 0.007
DID, difference in difference; NTDs, neural tube defects.
Absolute rate of decrease in prevalence=prevalence of group before folic acid supplementation–prevalence of group after folic acid 
supplementation.
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The prevalence of NTDs in Shanxi Province in northern 
China is historically high, being 105.5 per 10 000 births in 
the late 1980s22 and 138 per 10 000 births in 2003.23 In 
2009, the Ministry of Health of China initiated a nation-
wide FA supplementation programme for the purpose 
of further decreasing the occurrence of NTDs in the 
country.17 Women with a rural household registration 
and planning to become pregnant are eligible to obtain 
FA supplements free of charge through the maternal 
healthcare system. In a recent study, we showed that 
birth prevalence of NTDs in the five counties of Shanxi 
Province in northern China dropped dramatically, from 
118.9/10 000 in 2000 to 31.5/10 000 in 2014.18 However, 
differences between the sexes among this population 
have rarely been examined. One previous study reported 
a female predominance among anencephaly cases (male-
to-female RR 0.49; 95% CI 0.30–0.79) but not among 
spina bifida (RR 0.90; 95% CI 0.55 to 1.45) or enceph-
alocele (RR 1.03; 95% CI 0.40 to 2.69) cases in 200623; 
however, that study was conducted before the national 
FA supplementation programme and how the NTD prev-
alence has changed in each sex in association with the 
programme remains unknown.
Since 2009, the nationwide FA supplementation 
programme has provided FA supplements, free of charge, 
to all women who have a rural registration and who plan 
to become pregnant. As we previously reported, the prev-
alence of NTDs was dramatically lower in 2012–2014 than 
in 2009 in Shanxi Province. This decrease may be partially 
attributable to the programme; however, this decreasing 
trend has not continued since 2014. In fact, the preva-
lence in the same area was higher in 2015–2016 (32.8 per 
10 000 births) than in 2014 (31.5 per 10 000 births). More-
over, the prevalence of NTDs in this area remains high 
when compared with the rates in the USA,15 Canada,24 
Germany,25 England, Wales26and Western Australia.27 The 
compliance of women taking the FA pills may be attrib-
utable to the high prevalence. A previous study showed 
the percentage of folic acid supplementation before the 
last menstrual period increased only from 30% to 43% 
and the supplementation adherence of ≥8 days/10 days 
showed a decrease.28 Other reasons may need further 
study.
In addition to the NTD prevalence data, our previous 
cross-sectional surveys on the use of FA and blood folate 
concentration among pregnant women provide external 
evidence to test the correlation between folate status and 
NTDs. Those two surveys took place in the same area, 
one before the FA programme started (2003–2004)29 and 
the other after it started (2011–2012).30 Detailed descrip-
tions of the two studies have already been published.30 31 
Briefly, a face-to-face interview with a structured question-
naire including information on FA supplementation was 
conducted among women who was in their late first 
trimester or early second trimester of pregnancy. A 5 mL 
non-fasting blood sample was collected at the time of 
recruitment and plasma levels of folate were determined 
using a microbiological assay.32
Our previous cross-sectional study showed that the 
proportion of people taking FA supplements increased 
from 9.2% in 2003–200433 to 66.3% in 2011–201230. 
Comparison of population data on blood folate 
concentration among pregnant women and NTD 
prevalence data indicated a clear trend: plasma folate 
concentration increased from 10.4 nmol/L in 2003–
200433 to 33.4 nmol/L in 2011–201222 while the preva-
lence of NTDs decreased from 117.8/10 000 births to 
60.3/10 000 births, respectively.19 Women who took FA 
supplements had significantly higher folate concentra-
tions (median 41.9 nmol/L) than those who did not 
(13.2 nmol/L) in 2003–2004. In contrast, these values 
were 50.7 nmol/L and 17.3 nmol/L, respectively, in 
2011–2012. The prevalence of NTDs was lower among 
both men and women after the programme. However, 
the effect was not the same for men and women, being 
greater among women than men. For open NTDs, the 
decrease was 26.3/10 000 higher among women than 
men; for total NTDs (including encephalocele), the 
decrease was 30.7/10 000 higher among women than 
men in the current study.
Studies on mice have indicated that female embryos 
are more susceptible to NTDs than males in some, but 
not all, genetic models.34 For example, there is a higher 
rate of cranial NTDs in mice carrying mutations in 
Trp53,6 Pax3,or Nf135 but not Gldc.36 Sex differences in 
NTD susceptibility in Trp53 null mice may result from 
the presence of two X chromosomes and independent 
of the Y chromosome.6 Given the association between 
abnormal one-carbon metabolism or impaired methyla-
tion and NTDs, it has been hypothesised that the higher 
rate of cranial NTDs in females may be an epigenetic 
phenomenon. The demand for genomic DNA methyl-
ation is higher in females, which methylate most of the 
DNA in the large inactive X chromosome after every cell 
division. It is speculated that this may reduce the methyla-
tion capacity available for other key cellular needs.3 In the 
splotch (Sp2H; Pax3 mutant) strain, female susceptibility 
to exencephaly is exacerbated by dietary folate deficiency 
to a greater extent than in males.37 While the aetiology 
of human NTDs is more complex than in single-gene 
models, if such a scenario occurs in some human NTDs, 
then it might be predicted that an overall increase in 
population-level folate status may have a greater effect on 
NTDs in women than in men. This is consistent with our 
findings for anencephaly rates.
Genetic and environmental factors may also interact to 
determine murine sex ratios, with female embryos being 
more susceptible to lethality. In the splotch strain, for 
example, arsenite treatment and advanced maternal age 
are both associated with higher rates of in utero death 
and NTDs.38 Both factors result in elevated sex ratios 
(male:female) among litters, which suggests increased 
loss of female embryos by resorption. This effect is geno-
type-dependent such that a greater effect, with lower sex 
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A study of human NTDs indicated an overall excess of 
affected women, with the overall male:female sex distri-
bution of unaffected carrier or transmitting individuals 
being 0.64, and an even greater excess of female gene 
carriers, with a male:female ratio of 0.52, when only 
closely related relatives are counted.39 To fully under-
stand the genetic influences of NTDs, future studies 
are needed to investigate the importance of epigenetic 
factors and imprinting effects, methylation status and 
folate supplementation, as well as the gender of the child 
in altering NTD risk.
In fact, the larger decline in NTD prevalence among 
women is somewhat expected given that it was higher 
in the presupplementation time period. The difference 
between sexes which is less pronounced is consistent with 
prevalences beginning to converge toward the prevalence 
of NTDs that are not preventable by FA.
Our data are from a population-based surveillance 
system, which covered all live births (28 or more complete 
gestational weeks), and NTD cases from pregnancies of 
any gestational age. This could give a more precise esti-
mation of NTD rate than hospital-based surveillance 
systems that include only NTD cases in pregnancies of 28 
gestational weeks or greater in China.40
Three main limitations of our study should be 
mentioned. First, we included data from only five coun-
ties, and the results may not be generalisable to the entire 
province or country. Second, we did not include the 
detailed subtypes of spina bifida, such as high-level and 
low-level lesions, which may show different patterns. A 
future study may be useful to address this question. Third, 
as an ecological design in which some confounding 
factors might affect our results, the massive FA supple-
mentation programme was the only major factor that may 
affect the population rate of NTDs in the study. Improve-
ment in living standards and prenatal diagnosis may also 
impact the rate of NTDs, but these potential factors are 
not predicted to have a differential effect on men and 
women.
In conclusion, the prevalence of NTDs decreased in 
both sexes after the implementation of a massive FA 
supplementation programme, but to a greater degree 
(both total NTDs and open NTDs) in women.
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